Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Health

Multi-Billion Dollar Potential Market for COVD-19 Vaccine, Per Market Research Firm

Leave a comment


Kalorama Information logo

Only 45% of US adults tend to get the flu shot, depending on the severity of the flu season. Presumably, many more will rush to get the COVID-19 vaccine, and we expect more attention on flu as well because of the attention on respiratory disease transmission.


ARLINGTON, Va. (PRWEB)

As the COVID-19 outbreak advances worldwide, companies are stepping up to the challenge to develop a potential vaccine. There are over 75 confirmed COVID-19 vaccine candidates, five of which have already entered clinical trials. In its recent report on vaccine development, Kalorama Information, part of Science and Medicine Group, has tracked companies that are developing vaccines for COVID-19. The firm says that a vaccine for COVID-19 would create a market worth billions in revenue, perhaps even as much as ten billion, but that companies would also incur large R&D spends and production challenges which have always keep profit margins in the industry on the low side. Kalorama has covered vaccines in market research studies for two decades.

Vaccination protects not only individuals, but also entire communities from diseases spread by person-to-person transmission. When immunization programs achieve high levels of “community” immunity, the likelihood that an infected person will transmit the disease to a susceptible individual is greatly reduced. Vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related complications in the elderly. Pharmacoeconomic studies have demonstrated the value of influenza and pneumococcal vaccines; however, despite various vaccination campaigns and promotional efforts, immunization rates for these diseases continue to be low in the elderly population.

In the U.S., for example, the Centers for Disease Control (CDC) has found that Influenza is responsible for 20,000 to 40,000 deaths annually, and up to 50,000 deaths and an estimated 200,000 excess hospitalizations at a cost of $750 million to $1 billion during epidemic years. Also mortality from all pneumococcal disease, also vaccine-mitigatable, results in about 40,000 deaths annually, with morbidity estimated at 500,000 cases of pneumonia.

“Only 45% of US adults tend to get the flu shot, depending on the severity of the flu season,” said Bruce Carlson, Publisher of Kalorama Information. “Presumably, many more will rush to get the COVID-19 vaccine, and we expect more attention on flu as well because of the attention on respiratory disease transmission.”

Influenza vaccines generated $5.1 billion in revenues. Sales fluctuate from year to year with a variety of factors including new influenza strains and outbreaks, government contracts and stockpiling, new production formats and rising demand in developing countries affecting demand.

Roughly estimated market demand based on comparison to flu vaccine alone, Kalorama believes the market for COVID-19 could be 8-10 billion dollars in its first full year of implementation. It would represent a quarter of the vaccine market in that year.

“But there will likely be many factors that would move that number up or down,” said Carlson. “Price, supply, government intervention, stockpiling effects all could temporarily create a very large or smaller than expected market.”

Carlson also noted that such a vaccine could start out at a high market figure and then in the future settle down to a more stable number as it becomes standard and as competition is introduced, which has been the case with cervical cancer, travel and flu vaccines.

Many vaccine trials are underway, some for diseases such as breast cancer, HIV, and malaria. But because of the nature of the severity of the COVID-19 pandemic, vaccine manufacturers are prioritizing the development of COVID-19 vaccines. As of April 20, 2020, several candidates for a COVID-19 vaccine are showing promise:


  • CanSino Biologics is developing a vaccine for the prevention of COVID-19, Ad5-nCoV, a recombinant vaccine incorporating the adenovirus type 5 vector. On March 8, 2020, CanSino received approval from the Chinese authorities to begin human trials. This is the first coronavirus vaccine to advance to phase II trials.

  • Moderna offers its mRNA-1273, a novel lipid nanoparticle-encapsulated mRNA vaccine encoding for a perfusion-stabilized form of the SARS-CoV-2 spike protein. On March 16, 2020, the company began its phase I open-label, dose-ranging trial, occurring at Kaiser Permanente Washington Health Research Institute in Seattle. The company says it has applied for Phase II.

  • Inovio Pharmaceuticals announced that CEPI provided a grant to develop a vaccine against COVID-19 called INO-4800. The company is collaborating with Beijing Advaccine Biotechnology to advance the product. Preclinical testing has begun, with human clinical trials to commence in April 2020 in the U.S., China, and South Korea. It is anticipated that with positive results, some 1 million doses of the INO-4800 DNA vaccine can be produced by the end of 2020. On April 6, 2020, the company received approval to begin phase I trials. The Bill and Melinda Gates Foundation, along with other nonprofits, is supporting Inovio’s COVID-19 vaccine project.

  • Shenzhen Geno-Immune Medical Institute offers the LV-SMENP-DC vaccine. The LV-SMENP-DC vaccine is made by modifying dendritic cells (DC) with lentivirus vectors expressing COVID-19 minigene SMENP and immune-modulatory genes. CTLs will be activated by LV-DC presenting COVID-19 specific antigens. The project is in phase I.

  • Shenzhen Geno-Immune Medical Institute has a second product — the COVID-19/aAPC vaccine. The COVID-19/aAPC vaccine is prepared by applying lentivirus modifications, including immune-modulatory genes and the viral minigenes, to the artificial antigen-presenting cells (aAPCs). It is also in phase I.

Many vaccine trials are underway, some for diseases such as breast cancer, HIV, and malaria. But because of the nature of the severity of the COVID-19 pandemic, vaccine manufacturers are prioritizing the development of COVID-19 vaccines. As of April 20, 2020, several candidates for a COVID-19 vaccine are showing promise including CanSino, Moderna, Inovio and others. Kalorama Information’s vaccine production report is available at: https://kaloramainformation.com/product/vaccine-development-and-production-trends-covid-19-and-other-vaccines-pipeline/.

About Kalorama Information

For more than 30 years, Kalorama Information has been a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, healthcare, medical devices, and pharmaceuticals.

Share article on social media or email:

Health

Tipton Health Communications Guides Organization’s Toward the “New Normal” With Additional Webinars

Leave a comment



NEWARK, Del. (PRWEB)

As healthcare organizations continue to navigate and push forward through the challenges of the COVID-19 pandemic, attention is slowly starting to focus on what the “new normal” will look like in the months ahead as team members return to the workplace and hospitals resume elective procedures. To support the transition, Tipton Health Communications has added two additional webinars focused on preparing and adjusting for life in a COVID-19 world.

The webinars will be held on June 2 and June 9. For more information and to register, please visit tiptonhealth.com/webinars.

Employee Communications Essentials in the “New Normal” Hospital Environment

June 2, 12:30 – 1 p.m. EDT

Erin DiGirolamo, MPH, senior manager of Internal Communications and Digital Workforce Strategy at the Children’s Hospital of Philadelphia, and Phil Ellingsworth Jr., strategic communications manager at Tipton Health Communications, will discuss the best practices for nurse communications in a hospital environment forever changed by the pandemic.

How Nurse Autonomy Helped Hospitals Manage the Crisis (and Will Help Build the New Normal)

June 9, 12:30 – 1 p.m. EDT

Judi Hahn, director of Professional Practice and Nursing Education at Yale New Haven Hospital, will outline how nurse autonomy and nursing professional governance was key to helping hospitals manage the COVID-19 crisis. She also will touch on how autonomous nurses will help build the “new normal” of healthcare after the pandemic is behind us.

Tipton Health Communications continues to add webinars that try to help make sense of a complex world following the pandemic.

For more information on these upcoming webinars and the experts leading them, please visit tiptonhealth.com/webinars. Here you can also view recordings of our past sessions.

About Tipton Health Communications

Tipton Health Communications is a leading provider of executive nurse consulting and mentoring; nursing excellence program development; and Magnet®, Pathway to Excellence® and Practice Transition Accreditation Program™ consulting support to the nation’s hospital and healthcare systems. In addition, Tipton Health supports clients nationwide with award-winning communications services, including employee communications, human resources communications, public relations, marketing communications, intranet and Internet design, graphic design, and strategic communications. For more information, please visit tiptonhealth.com.

Tipton Health Communications products and services are neither sponsored nor endorsed by the ANCC. ANCC Magnet Recognition®, ANCC National Magnet Conference®, Institute for Credentialing Innovation®, Magnet®, Magnet Recognition Program®, The Magnet Prize® and Pathway to Excellence® Program are registered trademarks of the American Nurses Credentialing Center. Journey to Magnet Excellence™ and Pathway to Excellence in Long Term Care™ are trademarks of the American Nurses Credentialing Center.

Share article on social media or email:

Health

Healthy Food Financing Initiative Announces $3 Million Available in Funding

Leave a comment


“A resilient food system is essential to ensure that all Americans, regardless of where they live or how much they make, can get the food they need to keep their families healthy,” said Don Hinkle-Brown, President and CEO of Reinvestment Fund.


PHILADELPHIA (PRWEB)

Reinvestment Fund is inviting applications for funding through the 2020 round of the Healthy Food Financing Initiative (HFFI) Targeted Small Grants Program. Funding for the HFFI Targeted Small Grants Program is provided by the United States Department of Agriculture (USDA), authorized by the Farm Bill. Reinvestment Fund serves as the national fund manager for the HFFI program at USDA. The 2020 HFFI round significantly increases the available funding compared to the previous round, offering $3 million in grant funds for food retail and food enterprises working to improve access to healthy foods in underserved areas, to create and preserve quality jobs, and to revitalize low-income communities.

“A resilient food system is essential to ensure that all Americans, regardless of where they live or how much they make, can get the food they need to keep their families healthy,” said Don Hinkle-Brown, President and CEO of Reinvestment Fund. “The COVID-19 pandemic has underscored the need to sustain a robust food system that serves all communities. We hope that these HFFI investments can seed improved access to healthy food in underserved communities and also fundamentally strengthen local food economies.”

Financial assistance is available in the form of direct grants to projects selected through a competitive application process. Applicants can be food retail and/or non-retail food system enterprises that seek to improve access to healthy food in underserved areas through food retail. The HFFI grants program is open to eligible for-profit, nonprofit, and cooperatively owned businesses, institutions of higher education, state and local governments and tribal governments. Grants could assist projects with a variety of aspects of project development, renovation, and/or expansion. Grants are designed to be one-time investments of capital into a food retail or food enterprise project and aim to unlock additional sources of capital, catalyze project sustainability, meet financing gaps, and/or enable deeper impact or project reach.

In conjunction with the grants program, Reinvestment Fund will also provide technical assistance to support selected early stage projects where resources would help build local capacity to develop a food retail outlet or enterprise and would clarify or advance an eligible project.

The COVID-19 pandemic has revealed how essential grocery stores, food suppliers, and their employees are to providing essential goods and services to communities. The economic impact of the pandemic will only further constrain low-income families’ ability to afford and access healthy food. While the program is designed to support projects that respond to food access and food enterprise needs that were evolving prior to the COVID-19 outbreak, the program will also consider projects related to recovery from the pandemic, directly or indirectly.

The application has two phases–the first phase is a Letter of Interest, which is due on July 10, 2020. Eligible applicants will be invited to submit a full application in the second phase. The Request for Assistance (RFA), application materials and additional information are available at http://www.investinginfood.com. Questions may be directed to help@investinginfood.com. Reinvestment Fund is also hosting an informational webinar on the application process on June 2, 2020 at 2pm EST. Potential applicants can join the webinar at bit.ly/WebinarJune2. No registration is required.

An initiative of USDA Rural Development, HFFI projects and programs have also been supported by the U.S. Department of the Treasury and U.S. Department of Health and Human Services. Since 2010, HFFI programs have helped leverage more than $267 million in grants and an estimated $1 billion in additional financing. They have also supported nearly 1,000 grocery and other healthy food retail projects in more than 35 states across the country, revitalizing economies, creating jobs, and improving health.

###

About Reinvestment Fund

Reinvestment Fund is committed to building strong, more equitable communities by making health, wellbeing, and financial security available and accessible to families, regardless of income or zip code. We integrate data, policy and strategic investments to improve the quality of life in neighborhoods. Using analytical and financial tools, we bring high-quality grocery stores, affordable housing, schools and health centers to the communities that need better access-creating anchors that attract investment over the long term and help families lead healthier, more productive lives. Beginning with the Pennsylvania Fresh Food Financing Initiative (FFFI) in 2004, Reinvestment Fund has developed a comprehensive and evidence-based approach to improving the food landscape for low-income people. Since that time, it has provided $300 million in grants and loans to healthy food projects. Reinvestment Fund also founded and manages ReFresh, a capacity-building initiative that is composed of CDFI partners nationally, who are among the largest national practitioners in healthy food financing.

Share article on social media or email:

Health

Muscogee (Creek) Nation Partners with Tulsa-based RespirCare and HGE Health to Provide Employees with Innovative COVID Monitoring Application and Access to Same-Day Care

Leave a comment


“Through simple daily tracking of symptoms by our employees, we can protect employees and our citizens by identifying and treating potential cases early to prevent the spread of COVID-19,” said Shawn Terry, secretary of Health for the Muscogee (Creek) Nation.


OKMULGEE, Okla. (PRWEB)

The Muscogee (Creek) Nation Department of Health (“MCNDH”) has partnered with RespirCare and HGE Health to provide Muscogee (Creek) Nation employees with a free COVID monitoring application and access to same-day care.

MCN tribal employees have access to download for free, HGE COVID Care, a mobile application, to remotely monitor symptoms of COVID-19 regardless of whether they have tested positive for the virus. Should in-person care be needed, RespirCare, a full-service pulmonology clinic based in Tulsa, will provide same-day care through the clinic or via telemedicine.

“The COVID Care app is part of the tribe’s proactive screening program to keep employees and guests safe,” said Shawn Terry, secretary of Health for the Muscogee (Creek) Nation. “Through simple daily tracking of symptoms by our employees, we can protect employees and our citizens by identifying and treating potential cases early to prevent the spread of COVID-19.”

HGE COVID Care provides simple daily tracking of symptoms to provide early detection for patients at risk for developing severe symptoms. It takes users less than 1 minute a day to track symptoms and the recorded data is assessed by RespirCare’s remote care team to determine the degree of urgency and whether in-person testing and/or treatment is necessary. When a member reports symptoms or elevated risk, a qualified medical professional from RespirCare will call them directly to help them understand recommended next steps.

“By monitoring COVID-related symptoms and providing early detection, this program provides a reliable way for people and companies to get back to work safely,” said Mark Boomer, M.D., CEO and staff pulmonologist of RespirCare. “We developed this app as a way to help prioritize treatment options. For people with symptoms, we can have them evaluated same-day at RespirCare or at-home via telemedicine. In addition to helping people determine if and when they should be tested, we can also help people who have tested positive for COVID-19 manage treatment at home and advise if and when they need hospital care.”

The platform features an easy-to-use graphical interface that guides users through a questionnaire prepared in accordance with the Centers for Disease Control and Prevention COVID-19 guidelines. This is in addition to the standard respiratory symptoms tracked in the clinically validated HGE Health solution for respiratory illnesses. More information on COVID and COPD monitoring can be found at http://www.hgehealth.com.

About Muscogee (Creek) Nation Department of Health

Headquartered in Okmulgee, Oklahoma, the Muscogee (Creek) Nation is the fourth-largest tribe in the United States with more than 87,000 citizens. MCN Health serves more than 120,000 patients annually and provides inpatient and emergency services to both Indian and non-Native patients through its community hospitals.

About HGE Health

Headquartered in Fort Washington, Pennsylvania, HGE Health harnesses its deep experience in chronic disease management and digital health in pulmonary disease, telemedicine, and mobile health to develop a clinical services platform that delivers better care and faster at a much lower cost for patients, physicians, and payors. Built on clinical protocols developed and supported by 16 years of research, the company’s technology has compiled the longest-running and world’s largest longitudinal data set of COPD symptoms, interventions, and clinical management to help physicians provide care for a geographically and socio-economically diverse COPD and pulmonary patient population.

About RespirCare

Founded in Tulsa, Oklahoma, RespirCare is a novel clinic dedicated to treating acute and chronic respiratory conditions, from minor to the most severe. Remote symptom monitoring is offered to allow clinical interventions to be performed immediately, as symptoms begin to worsen. Treatment is available at RespirCare by appointment and as a walk-in clinic, which is open seven days a week to ensure immediate care is available when patients need it most. A separate waiting room available for contagious patients, and oxygen outlets throughout, establish a patient-centric waiting environment with patient wellbeing and comfort in mind. RespirCare offers regular and after-hours care for no more than the cost of a visit to your regular pulmonary specialist, avoiding the costs of an emergency department visit.

Share article on social media or email:

Health

New research offers regions a better way to understand and evaluate how to manage COVID-19

Leave a comment


The Health Risk Index very closely predicts the number of cases or deaths per city, based on that city’s unique risk factors.

The Health Risk Index very closely predicts the number of cases or deaths per city, based on that city’s unique risk factors.

COVID-19 is affecting every city and region differently, depending on their risk factors. We hope the Health Risk Index gives policymakers and leaders the comprehensive data they need to make informed, localized decisions that protect their most vulnerable citizens and sustain their economies,


MOSCOW, Idaho (PRWEB)

American leaders, business owners and citizens have a powerful new resource in the fight against COVID-19 with Emsi’s Health Risk Index.

Launched this week, the Health Risk Index (and accompanying analysis) uses four key risk factors to determine why COVID-19 has hit some regions harder than others—and predict future risk.

1. Population with preconditions

2. Population density

3. Workplace interaction

4. Overall population health

Dr. Wayne Gearey, Emsi’s SVP of data science and creator of the index, used his background in social epidemiology to create an interdisciplinary, location-based approach using the social determinants of health.

“COVID-19 is affecting every city and region differently, depending on their risk factors. We hope the Health Risk Index gives policymakers and leaders the comprehensive data they need to make informed, localized decisions that protect their most vulnerable citizens and sustain their economies,” Gearey said.

Local and state governments can use the index to predict future virus hotspots and deploy response strategies that limit risk for vulnerable people and places. Businesses can use it to evaluate their locations, the level of social interaction in the workplace and the health of their workforce. And individuals can use it to make personal decisions that reduce overall community risk.

“Emsi’s vision is to use data to help communities work together. Right now, we are in the midst of a tsunami,” said Emsi CEO Andrew Crapuchettes. “And now is the time to start using data to make better decisions to help communities avoid risk and, as those tsunami waters start to recede, help Americans get back to work and restart their livelihoods.”

For more information about Emsi’s Health Risk Index, contact Rob Sentz at rob@economicmodeling.com.

###

About Emsi:

Founded in 2001, Emsi is a labor market analytics firm that uses data to drive economic prosperity. Emsi works with professionals in higher education, economic development, workforce development, talent acquisition, real estate and site selection. Headquartered in Moscow, Idaho, with offices in the U.K. and Dallas, Emsi serves clients across the U.S., the U.K., Canada and Australia.

Share article on social media or email:

Health

FirstService Residential Increases Recruitment to Support Hospitality Workers Displaced by COVID-19 Closures

Leave a comment



HOLLYWOOD, Fla. (PRWEB)

FirstService Residential, North America’s property management leader, has launched initiatives to provide employment for hospitality workers impacted by the COVID-19 pandemic.

While many hospitality brands have reduced or eliminated their workforce due to temporary closures caused by the pandemic, FirstService Residential is hiring displaced workers to meet the growing needs of its managed communities.

“Residential property management is an essential service and a fairly recession-resistant industry which makes it an attractive alternative for hospitality workers who lost their jobs during this challenging time,” said David Diestel, south region president, FirstService Residential.

With more than 2,500 managed communities across South Florida and a constant demand for staff, FirstService Residential has partnered with hospitality associations and local hotels to promote employment opportunities to their networks and ramped up recruitment efforts via a dedicated Career Source page on their website, virtual interviews and job fairs and collaboration with recruiting platforms.

As the nation continues to navigate through this unprecedented time, FirstService remains focused on its mission to make a difference, every day, in the communities they manage. In addition to keeping their communities staffed with the best talent in the industry, they are keeping them safe by providing masks, gloves and other Personal Protection Equipment (PPE).

About FirstService Residential

FirstService Residential is North America’s property management leader, partnering with more than 8,000 communities across the U.S. and Canada, including low-, mid-, and high-rise condominiums and cooperatives; single-family communities; master-planned, lifestyle and active adult communities; and mixed-use and rental properties. HOAs, community associations, condos and strata corporations rely on their extensive experience, resources and local expertise to maximize property values and enhance their residents’ lifestyles. Dedicated to making a difference, every day, FirstService Residential goes above and beyond to deliver exceptional service.

FirstService Residential is a subsidiary of FirstService Corporation (FSV), a North American leader in the property services sector. For more information, visit http://www.fsresidential.com.

Share article on social media or email:

Health

Renal Support Network Announces 18th Annual Essay Contest Theme

Leave a comment


Annual Essay Contest for people who have kidney disease

RSN’s 18th Annual Essay Contest

“There is an abundance of talent within the renal patient community, and the RSN Essay Contest provides people who have kidney disease with a forum where they can share their experiences, strengths and hope. I look forward to hearing about people’s flavorful food experiences.” –Lori Hartwell


GLENDALE, Calif. (PRWEB)

Renal Support Network (RSN), a nonprofit, patient-run organization, encourages people with kidney disease to share their inspirational stories by entering their 18th Annual Essay Contest. This year’s theme is “Thriving No Matter What I Can or Can’t Eat: A Happy Food Experience on the Kidney Diet.”

RSN’s Annual Essay Contest provides a unique opportunity for people with chronic kidney disease (CKD), including people who have CKD, are on dialysis or have a kidney transplant, to have a voice and express their ideas, methods, coping strategies and most importantly to RSN, hope. It is a chance to share interesting food anecdotes and discoveries that have improved health, well-being, and the daily routine of living with a chronic illness where smart food choices are a key element.

Lori Hartwell, RSN’s founder and president, author of Chronically Happy: Joyful Living in Spite of Chronic Illness and host of KidneyTalk Podcast, says, “People who live successfully with a chronic illness like kidney disease know firsthand the importance of having an innovative perspective and strategy not only toward their illness, but also toward life in general.” She added, “There is an abundance of talent within the renal patient community, and the RSN Essay Contest provides people who have kidney disease with a forum where they can share their experiences, strengths, hope and inspire others. I look forward to hearing about people’s flavorful food experiences.”

All submissions must be written by someone who has been diagnosed with CKD and must be a maximum of 750 words.

Contest winners will receive cash prizes: First Place, $500; Second Place, $300; and Third Place, $100. The submission deadline is August 10, 2020. Winners will be announced on the week of September 21, 2020, and winning essays will be featured in RSN’s publication KidneyTalk™ Magazine and on RSNHope.org.

For information about the contest, rules and to read previous winning essays, visit RSN’s Essay Contest Web Page

RSN would like to thank Akebia, Fresenius Kidney Care, National Renal Administrators Association and U.S. Renal Care for their support of this valuable patient engagement program.

—————————————————————————————–

The Renal Support Network (RSN) is a nonprofit patient-run organization that provides non-medical services to those affected by chronic kidney disease. RSN strives to help patients (dialysis, kidney transplant, and newly diagnosed patients) develop their personal coping skills, special talents, and employability by educating and empowering them to take control of the course and management of the disease. http://www.RSNhope.org

Share article on social media or email:

Health

Luminec Pharmaceuticals submits Coronavirus countermeasures to U. S. health officials

Leave a comment



CARLSBAD, Calif. (PRWEB)

Luminec Pharmaceuticals, Inc. announced that it will submit a market research package to BARDA (Biomedical Advanced Research and Development Authority) in response to the currently-open broad agency announcement soliciting proposals for the development of COVID-19 disease countermeasures.

The submission will include technical information outlining the benefits and mechanism of action of the CRO-50 and X-2 products. It will also include multiple clinical case documents, including diagnosis, treatment and outcomes of patients treated with these products in previous severe acute respiratory syndrome coronavirus outbreaks (SARS-CoV-2). These products are based on ground-breaking research started by Professor Heberto Alcázar-Montenegro, co-founder of the Albert Szent-Györgyi Gerontological Center and the Hans Selye Institute of Scientific Research, and continued by his daughter, Dr. Susana Alcázar-Leyva, who currently serves as president of both institutions. Dr. Alcázar-Leyva is also a co-founder and director since 1986 of the Albert Szent-Györgyi Gerontology Center and serves Luminec Pharmaceuticals as its Executive Advisor and Board Director.

“We are pleased to offer our technology, historical clinical data and products for consideration in mitigating this current health issue” said Dr. Stephen Holt, Professor Emeritus and Co-Founder and Director of Scientific Development, Luminec Pharmaceuticals.

About Luminec Pharmaceuticals

Headquartered in Carlsbad, CA, Luminec Pharmaceuticals currently offers a unique array of all-natural OTC products and clinical services for both human and animal use. Luminec’s products include natural proprietary formulations based on the Schutt Paradigm of Free Amino Ion Alignment & Molecular Stability, in combination with proprietary partner technologies and nanoparticle delivery systems.

Luminec Pharmaceuticals is a wholly-owned subsidiary of Luminec Holding Corporation, a private holding company.

Share article on social media or email:

Health

Good Medicine Choice, Inc. Launches Good Medicine Choice Network Health Blog, Coronavirus Education Podcast, Product Line in Response to COVID-19 Pandemic

Leave a comment


Good Medicine Choice™ Network

Good Medicine Choice™ Network

“We aim to provide information on how to protect yourself and your family not just during the current pandemic crisis but also in the future, as our highly connected world presents the risk of future threats to your health,” said Thomas J. Lewis, Ph.D.


EAST STROUDSBURG, Pa. (PRWEB)

Good Medicine Choice, Inc., a collaborative network of research scientists and practitioners, has launched a new health blog, Podcast and product line in their efforts to fight the Coronavirus pandemic. The website, GoodMedicineChoiceNetwork.com, offers guidance on maintaining a healthy immune system and supplemental products to protect against chronic and infectious diseases.

The site will donate 10% of profits from product sales to support charities, including Advocates for Disabled Americans, Veterans, Police, Fireman & Families (ADA VETs).

Good Medicine Choice, Inc., (GMC) has researched and developed a variety of health products including anti-inflammatory and antioxidant supplements, multivitamins and essential oils under the trademark “Good Medicine Choice.” Visit http://www.goodmedicinechoicenetwork.com/shop/ to learn more. The site also hosts a new podcast, Coronavirus Education, which is available for download on Apple iTunes, Stitcher and TuneIn.

The Good Medicine ChoiceTM Network website is provided as a resource by a network of doctors and specialists with expertise in telemedicine, chronic disease, immune system health, integrative medicine and pharmaceutical and medical device research and development. Main partners of GMC include MJA Research and Development, Inc., which leads the company in intellectual property and product development, as well as GoMD Virtual Healthcare Network, championing the company’s telemedicine efforts.

GMC has spent the last three months at the forefront of efforts to fight the coronavirus pandemic. Formed in 2016, GMC established a virtual healthcare network to provide medical assessments during the shutdown and is participating in a six-month research study into Cytokine Storms resulting from COVID-19 disease. The principals include Mikhail Artamonov, MD; Thomas J. Lewis, PhD; and Michael Carter, MD.

Good Medicine Choice Network focuses on how to avoid exposure to SARS-CoV-2 and other infectious disease, risks associated with severe symptoms or even dying from COVID-19, and how individuals can measure and reverse their risks of chronic conditions and infection. The website also provides information on testing and treatment research and resources related to coping during the pandemic are made available.

“I’m particularly proud of the fact that 10% of the company’s profits are contributed to charities including ADA VETs, an organization working closely with families of disabled veterans,” says Dr. Artamonov, CEO.

Podcast Features Latest Research on SARS-CoV-2 and COVID-19

Featuring research and information from Dr. Lewis and his colleague Dr. Carter, the Coronavirus Education Podcast covers topics that explore what it means to be immunocompromised, how to strengthen immunity from viruses, and symptoms and potential treatments for COVID-19.

“We aim to provide information on how to protect yourself and your family not just during the current pandemic crisis but also in the future, as our highly connected world presents the risk of future threats to your health,” added Lewis.

About the Good Medicine Choice Network Experts

Dr. Mikhail Artamonov, CEO, is a medical practitioner and cofounder of GoMD, a virtual healthcare provider that has worked to develop technologies for the healthcare industry. Dr. Artamonov earned his medical degree the 1st Moscow Medical Sechenov School, and over the course of his career trained in several specialties including Neurology and Physiatry, Anesthesiology, Psychiatry, and Internal and Integrative Medicine. Dr. Artamonov trained in major institutions around the world including Harvard and Cornell universities. He is Board Certified in eight major areas of Medicine, including Physical Medicine and Rehabilitation; Pain Medicine; Functional, Regenerative and Anti-Aging Medicine.

Thomas J. Lewis, Ph.D. studied at MIT and continued his education at Harvard School of Public Health. Since his father’s death 20 years ago of Alzheimer’s disease, he has dedicated his life to determining how to better predict Alzheimer’s and chronic diseases with a mission to replace the current “sick care” standard-of-care approach with a true “health care” approach. He is a healthcare professional with expertise in toxic substances, drug development, biotechnology and medical protocol development. Working with key clinicians at Harvard Medical School, his team developed an advanced diagnostic protocol, “4-Dimensions of Health,” utilizing AI-driven algorithms to measure risks and other determinants of chronic disease root cause prevention, screening and treatment.

Dr. Michael Carter is a board-certified physician and CMO of Functional Medicine at GoMD and Health Revival Partners. Over the past 10 years, Dr. Carter has expanded his education into functional or root-cause medicine. He has obtained certifications in topics including stem cells, energy medicine, nutrition and advanced peptides. Dr. Carter is co-inventor of the 4-Dimensions of Health program. He also is a member of the American Academy of Anti-Aging Medicine and the Institute for Functional. He completed his medical degree at Howard University and College of Medicine and his residency at Emory University School of Medicine.

Share article on social media or email: